Abstract
EPR, MOX or IVM administrated orally to chicks increased the mortality of D. gallinae, significantly slowed down their blood-meal digestion and significantly reduced their reproductive capability which included the oviposition rate, fecundity and egg hatching rate. The present study highlights the potential of MLs in the control of PRMs.
Introduction
The poultry red mite (PRM), Dermanyssus gallinae, is a major economic threat to the global egg industry, causing anemia, stress, and decreased egg quality. Traditional control methods rely on topical acaricide sprays, which often fail because mites hide in deep crevices during the day and have developed widespread chemical resistance.
This research investigates a systemic approach: administering macrocyclic lactones (MLs) orally to host birds. By delivering the drug via the bird's blood, every mite that feeds receives a dose, bypassing the need to reach hidden mites with surface sprays.
Methodology
The study evaluated three macrocyclic lactones—eprinomectin (EPR), moxidectin (MOX), and ivermectin (IVM)—using 6-week-old chicks. The birds received a single oral dose of 5.0 mg/kg. Following treatment, each chick was infested with 200 starved adult female mites. Engorged mites were collected after 12 hours and monitored for 10 days to assess:
- Acaricidal Efficacy: Daily mortality rates.
- Reproductive Impact: Oviposition (egg-laying) rates, fecundity, and hatching success.
- Digestion Rate: Microscopic observation of blood-meal processing over 5 days.
Comparative Efficacy of MLs
The results demonstrated that eprinomectin (EPR) is the most effective systemic treatment among those tested. While all three drugs increased mite mortality compared to the control group, EPR achieved a superior kill rate.
By Day 10, EPR reached 100% efficacy. In comparison, IVM reached 71.32%, and MOX achieved only 45.60%. The data suggests that EPR provides a more rapid and complete elimination of the mite population compared to other MLs at the same dosage.
Disruption of Digestion and Reproduction
A key finding of this research is the sublethal impact of MLs on mite physiology. The drugs did not prevent mites from feeding, but they severely inhibited the digestion of the blood meal.
As shown in the visual evidence, control mites became nearly transparent by Day 3 as they processed their meal. In contrast, mites fed on EPR-treated chicks retained dark, undigested blood. This "indigestion" directly correlates with reproductive failure. In the EPR group, the oviposition rate dropped to a mere 1.04% (vs 95.81% in control), and the egg hatching rate was reduced to zero.
Discussion and Future Directions
The study highlights that chicks require significantly higher doses of MLs (5 mg/kg) for efficacy compared to typical mammalian treatments. This may be due to avian metabolic differences or lower mite sensitivity.
While oral EPR shows immense promise, several hurdles remain for commercial use. The primary concern is the potential for drug residues in eggs, necessitating rigorous withdrawal period studies. Additionally, future research should explore practical delivery methods, such as administration via drinking water, and validate these findings in large-scale field environments.
Conclusion
Systemic treatment with oral eprinomectin offers a powerful, multi-pronged defense against D. gallinae. By combining high mortality with the total collapse of reproductive cycles through digestive disruption, MLs provide a viable alternative to traditional topical pesticides.
Summary updated